Search
Mind Medicine Subordinate Voting Ord Shs
DFTXAdd to Watchlist
37.245USD
-3.075-7.63%
Market hours 09/23, 14:35（ET）
4.64BMarket Cap
LossP/E TTM
DFTX Analyst Recommendation Trends
In the current month, DFTX has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DFTX average Analyst price target in the last month is 71.882.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
7
7
6
6
6
5
5
4
11
11
10
10
10
9
10
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18
18
16
16
16
14
15
14
Financial Forecasting
Based on analysts' estimates, DFTX EPS is projected to reach -0.557 in FY2026Q3, following reported EPS of -1.436 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.49
-0.49
-0.55
-0.56
-0.53
Actual
-0.50
-0.71
-1.44
--
--
Surprise
-2.39%
-44.00%
-162.75%
--
--
FAQs
How have Mind Medicine Subordinate Voting Ord ShsDFTX's recent earnings per share performed?
The market expectation was USD -1.44, while Mind Medicine Subordinate Voting Ord ShsDFTX's earnings per share (EPS) for the previous quarter was USD -0.71. EPS for the next quarter is expected at USD -0.56.
What is the analyst rating for Mind Medicine Subordinate Voting Ord Shs?
Based on the ratings of Mind Medicine Subordinate Voting Ord Shs's stock from 18 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.